StockTipsArenaBeta

BUY Sun Pharmaceutical Industries Ltd. — Sumeet Bagadia, Choice Broking

BUYSun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries share price target & all analyst calls

bySumeet Bagadia, Choice BrokingHorizon: NA (inferred Intraday)23 Oct 2026, 8:54 am ISTvia Zee Business (Live)

Entry₹1,757.4Inferred
Target₹1,790
Total upside +1.86%
Stop loss₹1,730-1.56% risk
CMP₹1,744.4Just now
Active-0.74%+2.61%upside left 3h left
Follow Sumeet Bagadia for new calls(11% target hit, 76 closed calls)Get alertsWatch SUNPHARMA for new buy/sell callsGet alertsSee 5 other Intraday picks this session

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 23 Oct, 11:25 am IST
2 supporting3 neutral0 opposing
Supports the BUY call (2)

Sun Pharma's drug UNLOXCYT (cosibelimab-ipdl) received a Category 2A preferred designation in the updated NCCN guidelines for locally advanced cutaneous squamous cell carcinoma.

NSE · Press Release·20 Oct · 2d ago

(opens in new tab)

Sun Pharma's drug UNLOXCYT (cosibelimab-ipdl) has been elevated to a Category 2A preferred designation in the NCCN Guidelines for locally advanced cutaneous squamous cell carcinoma (laCSCC).

BSE · Company Update·20 Oct · 2d ago

(opens in new tab)
Neutral / worth noting (3)

Q2 FY27 results scheduled — board meets 30 Oct 2026

BSE · Board Meeting·In 7 days

(opens in new tab)

Sun Pharma to raise Rs 10,000 crore to part-finance Organon deal

NewsEt-Markets·21 Oct · 2d ago

(opens in new tab)

Pharma Q2 Outlook: Pricing pressure, US competition to weigh on select players

NewsEt-Markets·19 Oct · 4d ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Sun Pharmaceutical Industries

All analyst calls on Sun Pharmaceutical Industries

More from Sumeet Bagadia, Choice Broking

Every call and its outcome